Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

A cost analysis of the treatment of first-line uncomplicated malaria in the Tonga district of Mpumalanga

Following the completion of a detailed baseline study of malaria in the region, a model was developed to assess the cost-effectiveness of switching from chloroquine to sulfadoxine-pyrimetharnine as first line treatment in the Tonga district of Mpumalanga, South Africa, where malaria is seasonal and...

Full description

Saved in:
Bibliographic Details
Main Author: Wilkins, Justin
Other Authors: Barnes, Karen I
Format: Thesis
Language:English
Published: Division of Clinical Pharmacology 2018
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867614368819052544
access_status_str Open Access
author Wilkins, Justin
author2 Barnes, Karen I
author_browse Barnes, Karen I
Wilkins, Justin
author_facet Barnes, Karen I
Wilkins, Justin
author_sort Wilkins, Justin
collection Thesis
description Following the completion of a detailed baseline study of malaria in the region, a model was developed to assess the cost-effectiveness of switching from chloroquine to sulfadoxine-pyrimetharnine as first line treatment in the Tonga district of Mpumalanga, South Africa, where malaria is seasonal and the population is non-immune. In vivo drug resistance was used to create a resistance variable, which was used to assess the 1997 relative costs to the health care system of employing the two drugs, analysing factors such as drug costs, staff time, transport costs, maintenance costs, utility costs, training costs and consumables costs to generate an average cost-effectiveness ratio. The model was subsequently used to estimate the average cost-effectiveness ratios of nine other potential agents for the treatment of first line malaria, including artesunate monotherapy, artesunate combinations, pyronaridine, atovaquone-proguanil, co-artemether, halofantrine, amodiaquine, and mefloquine. It was found that sulfadoxinepyrimethamine was 5 times more cost-effective as first line therapy than chloroquine. Of the other modelled drugs, it was recommended that an artesunate combination should be implemented when it becomes necessary to replace sulfadoxine-pyrimethamine; artesunate-mefloquine and artesunate-SP were estimated to be 6 times and 9 times as cost-effective as chloroquine, respectively.
format Thesis
id oai:open.uct.ac.za:11427/26763
institution University of Cape Town (South Africa)
language eng
last_indexed 2026-06-10T12:50:56.494Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2018
publishDateRange 2018
publishDateSort 2018
publisher Division of Clinical Pharmacology
publisherStr Division of Clinical Pharmacology
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/26763 A cost analysis of the treatment of first-line uncomplicated malaria in the Tonga district of Mpumalanga Wilkins, Justin Barnes, Karen I Folb, Peter I Pharmacology Following the completion of a detailed baseline study of malaria in the region, a model was developed to assess the cost-effectiveness of switching from chloroquine to sulfadoxine-pyrimetharnine as first line treatment in the Tonga district of Mpumalanga, South Africa, where malaria is seasonal and the population is non-immune. In vivo drug resistance was used to create a resistance variable, which was used to assess the 1997 relative costs to the health care system of employing the two drugs, analysing factors such as drug costs, staff time, transport costs, maintenance costs, utility costs, training costs and consumables costs to generate an average cost-effectiveness ratio. The model was subsequently used to estimate the average cost-effectiveness ratios of nine other potential agents for the treatment of first line malaria, including artesunate monotherapy, artesunate combinations, pyronaridine, atovaquone-proguanil, co-artemether, halofantrine, amodiaquine, and mefloquine. It was found that sulfadoxinepyrimethamine was 5 times more cost-effective as first line therapy than chloroquine. Of the other modelled drugs, it was recommended that an artesunate combination should be implemented when it becomes necessary to replace sulfadoxine-pyrimethamine; artesunate-mefloquine and artesunate-SP were estimated to be 6 times and 9 times as cost-effective as chloroquine, respectively. 2018-01-09T08:57:37Z 2018-01-09T08:57:37Z 1999 Master Thesis Masters MSc (Med) http://hdl.handle.net/11427/26763 eng application/pdf Division of Clinical Pharmacology Faculty of Health Sciences University of Cape Town
spellingShingle Pharmacology
Wilkins, Justin
A cost analysis of the treatment of first-line uncomplicated malaria in the Tonga district of Mpumalanga
thesis_degree_str Master's
title A cost analysis of the treatment of first-line uncomplicated malaria in the Tonga district of Mpumalanga
title_full A cost analysis of the treatment of first-line uncomplicated malaria in the Tonga district of Mpumalanga
title_fullStr A cost analysis of the treatment of first-line uncomplicated malaria in the Tonga district of Mpumalanga
title_full_unstemmed A cost analysis of the treatment of first-line uncomplicated malaria in the Tonga district of Mpumalanga
title_short A cost analysis of the treatment of first-line uncomplicated malaria in the Tonga district of Mpumalanga
title_sort cost analysis of the treatment of first line uncomplicated malaria in the tonga district of mpumalanga
topic Pharmacology
url http://hdl.handle.net/11427/26763
work_keys_str_mv AT wilkinsjustin acostanalysisofthetreatmentoffirstlineuncomplicatedmalariainthetongadistrictofmpumalanga
AT wilkinsjustin costanalysisofthetreatmentoffirstlineuncomplicatedmalariainthetongadistrictofmpumalanga